These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34964350)

  • 21. An integrated enrichment system to facilitate isolation and molecular characterization of single cancer cells from whole blood.
    Yu L; Sa S; Wang L; Dulmage K; Bhagwat N; Yee SS; Sen M; Pletcher CH; Moore JS; Saksena S; Dixon EP; Carpenter EL
    Cytometry A; 2018 Dec; 93(12):1226-1233. PubMed ID: 30549400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
    Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
    Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DEPArray™ system: An automatic image-based sorter for isolation of pure circulating tumor cells.
    Di Trapani M; Manaresi N; Medoro G
    Cytometry A; 2018 Dec; 93(12):1260-1266. PubMed ID: 30551261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optofluidic real-time cell sorter for longitudinal CTC studies in mouse models of cancer.
    Hamza B; Ng SR; Prakadan SM; Delgado FF; Chin CR; King EM; Yang LF; Davidson SM; DeGouveia KL; Cermak N; Navia AW; Winter PS; Drake RS; Tammela T; Li CM; Papagiannakopoulos T; Gupta AJ; Shaw Bagnall J; Knudsen SM; Vander Heiden MG; Wasserman SC; Jacks T; Shalek AK; Manalis SR
    Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2232-2236. PubMed ID: 30674677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in microfluidic technologies for circulating tumor cells: enrichment, single-cell analysis, and liquid biopsy for clinical applications.
    Pei H; Li L; Han Z; Wang Y; Tang B
    Lab Chip; 2020 Nov; 20(21):3854-3875. PubMed ID: 33107879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Microfluidic Chip for Efficient Circulating Tumor Cells Enrichment, Screening, and Single-Cell RNA Sequencing.
    Shi F; Jia F; Wei Z; Ma Y; Fang Z; Zhang W; Hu Z
    Proteomics; 2021 Feb; 21(3-4):e2000060. PubMed ID: 33219587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of rare circulating tumour cells in cancer patients by microchip technology.
    Nagrath S; Sequist LV; Maheswaran S; Bell DW; Irimia D; Ulkus L; Smith MR; Kwak EL; Digumarthy S; Muzikansky A; Ryan P; Balis UJ; Tompkins RG; Haber DA; Toner M
    Nature; 2007 Dec; 450(7173):1235-9. PubMed ID: 18097410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Affinity Versus Label-Free Isolation of Circulating Tumor Cells: Who Wins?
    Murlidhar V; Rivera-Báez L; Nagrath S
    Small; 2016 Sep; 12(33):4450-63. PubMed ID: 27436104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative-Selection Enrichment of Circulating Tumor Cells from Peripheral Blood Using the Microfluidic CTC-iChip.
    Burr R; Edd JF; Chirn B; Mishra A; Haber DA; Toner M; Maheswaran S
    Methods Mol Biol; 2022; 2471():309-321. PubMed ID: 35175606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The RareCyte® platform for next-generation analysis of circulating tumor cells.
    Kaldjian EP; Ramirez AB; Sun Y; Campton DE; Werbin JL; Varshavskaya P; Quarre S; George T; Madan A; Blau CA; Seubert R
    Cytometry A; 2018 Dec; 93(12):1220-1225. PubMed ID: 30277660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells.
    Khoo BL; Warkiani ME; Tan DS; Bhagat AA; Irwin D; Lau DP; Lim AS; Lim KH; Krisna SS; Lim WT; Yap YS; Lee SC; Soo RA; Han J; Lim CT
    PLoS One; 2014; 9(7):e99409. PubMed ID: 24999991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. All-in-One Microfluidic Chip for Online Labeling, Separating, and Focusing Rare Circulating Tumor Cells from Blood Samples Followed by Inductively Coupled Plasma Mass Spectrometry Detection.
    Xu Y; Chen B; He M; Cui Z; Hu B
    Anal Chem; 2023 Sep; 95(37):14061-14067. PubMed ID: 37677145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-purity and label-free isolation of circulating tumor cells (CTCs) in a microfluidic platform by using optically-induced-dielectrophoretic (ODEP) force.
    Huang SB; Wu MH; Lin YH; Hsieh CH; Yang CL; Lin HC; Tseng CP; Lee GB
    Lab Chip; 2013 Apr; 13(7):1371-83. PubMed ID: 23389102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA).
    Palmirotta R; Lovero D; Silvestris E; Felici C; Quaresmini D; Cafforio P; Silvestris F
    Cancer Genomics Proteomics; 2017; 14(3):173-179. PubMed ID: 28446532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Manipulation of a Single Circulating Tumor Cell Using Visualization of Hydrogel Encapsulation toward Single-Cell Whole-Genome Amplification.
    Yoshino T; Tanaka T; Nakamura S; Negishi R; Hosokawa M; Matsunaga T
    Anal Chem; 2016 Jul; 88(14):7230-7. PubMed ID: 27299849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Live single cell mass spectrometry reveals cancer-specific metabolic profiles of circulating tumor cells.
    Abouleila Y; Onidani K; Ali A; Shoji H; Kawai T; Lim CT; Kumar V; Okaya S; Kato K; Hiyama E; Yanagida T; Masujima T; Shimizu Y; Honda K
    Cancer Sci; 2019 Feb; 110(2):697-706. PubMed ID: 30549153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microfluidics and circulating tumor cells.
    Dong Y; Skelley AM; Merdek KD; Sprott KM; Jiang C; Pierceall WE; Lin J; Stocum M; Carney WP; Smirnov DA
    J Mol Diagn; 2013 Mar; 15(2):149-57. PubMed ID: 23266318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives.
    Gribko A; Künzel J; Wünsch D; Lu Q; Nagel SM; Knauer SK; Stauber RH; Ding GB
    Int J Nanomedicine; 2019; 14():4187-4209. PubMed ID: 31289440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Device for whole genome sequencing single circulating tumor cells from whole blood.
    Li R; Jia F; Zhang W; Shi F; Fang Z; Zhao H; Hu Z; Wei Z
    Lab Chip; 2019 Sep; 19(19):3168-3178. PubMed ID: 31455953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence.
    Garcia J; Barthelemy D; Geiguer F; Ballandier J; Li KW; Aurel JP; Le Breton F; Rodriguez-Lafrasse C; Manship B; Couraud S; Payen L
    J Vis Exp; 2019 Aug; (150):. PubMed ID: 31475991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.